Luteolin
Snapshot
| Indications | Contraindications |
|---|---|
Luteolin is a flavone found in celery, parsley, chamomile, and other herbs8. It acts through antioxidant and anti-inflammatory effects, including inhibition of microglia and mast cells5. That neuroinflammation rationale drives supplementation for brain fog, behavior in autism spectrum disorder, and persistent symptoms after coronavirus disease 2019 (COVID-19)5. A chlorogenic acid combination has also been studied for cardiometabolic parameters in pre-obesity.
Controlled evidence is narrow. In a 2023 randomized trial of patients with persistent smell loss after COVID-19, palmitoylethanolamide (PEA) co-ultramicronized with luteolin plus olfactory training produced greater recovery than either alone1. Autism data come from an open-label pilot, and diabetes claims rest largely on preclinical work. In a 2026 observational cohort of diabetic adults, higher luteolin intake was associated with lower kidney damage prevalence and better survival; no trial has tested this. Products are mostly capsules and often paired with PEA; low oral bioavailability is the main formulation issue, see Form comparison.
Per United States product labels, some advise consulting a doctor before use with anticoagulant medications7.
Last updated October 17, 2026. Read how we make monographs.
In the full monograph
37 sources, 22 studies
- When to useThe situations practitioners use it for, each with the reason and the study behind it.
- SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
- InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
- Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
- How it worksWhat it is and how it works in the body, in plain terms.
- Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
- Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
- Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.
Sources
- 1Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial.pubmed.ncbi.nlm.nih.govDi Stadio, Gallina, Cocuzza et al. · European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023 · Pubmed
- 2Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome.pubmed.ncbi.nlm.nih.govVersace, Ortelli, Dezi et al. · Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2023 · Pubmed
- 3What Is the Role of Palmitoylethanolamide Co-Ultramicronized with Luteolin on the Symptomatology Reported by Patients Suffering from Long COVID? A Retrospective Analysis Performed by a Group of General Practitioners in a Real-Life Setting.pubmed.ncbi.nlm.nih.govPirro, Ferri, Piccioni et al. · Nutrients · 2023 · Pubmed
- 4An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders.pubmed.ncbi.nlm.nih.govTaliou, Zintzaras, Lykouras et al. · Clinical therapeutics · 2013 · Pubmed
- 5Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin.pubmed.ncbi.nlm.nih.govTheoharides, Stewart, Hatziagelaki et al. · Frontiers in neuroscience · 2015 · Pubmed
- 6A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study.pubmed.ncbi.nlm.nih.govTerzo, Amato, Magán-Fernández et al. · Nutrients · 2023 · Pubmed
- 7US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm
- 8The Novel Approaches to Extraction Techniques, Drug Delivery Technologies, Pharmacological Applications, Patents of the Potent Flavonoid 'Luteolin': An Appraisal.pubmed.ncbi.nlm.nih.govAkanksha, Kumar, Aqil et al. · Chemistry & biodiversity · 2025 · Pubmed